Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
letter
. 2021 Feb 20;138(3):219–220. doi: 10.1016/j.anorl.2021.02.010

Sudden sensorineural hearing loss and SARS-CoV-2: Don’t forget the standard work-up!

C Guigou 1,*, A-D Schein 1, C Blanchard 1, M Folia 1
PMCID: PMC7896815  PMID: 33637430

Dear Editor-in-Chief,

A growing number of cases of sudden onset of isolated hearing loss are being described as a feature of SARS-CoV-2 infection [1]. Auditory neuropathy associated with cochleitis has already been described in the context of viral infection [2]. Several mechanisms have been proposed: either an indirect mechanism via an antibody response that would cross-react with an inner ear antigen, or a direct mechanism due to invasion of the cochlear nerve or anterior labyrinth [2]. In the context of the ongoing COVID-19 pandemic, SARS-CoV-2 RT-PCR should therefore be considered in patients with sudden hearing loss. However, even when RT-PCR is positive, a comprehensive work-up must be performed. We describe the case of a 29-year-old man with no prior history who attended our clinic with sudden onset of bilateral hearing loss occurring 10 days previously, with no other signs on clinical examination. As his wife reported anosmia-ageusia, Reverse Transcription Polymerase Chain Reaction (RT-PCR) SARS-CoV-2 was performed and proved to be positive. Audiometry revealed moderate bilateral sensorineural hearing loss. Cochleitis associated with bilateral auditory neuropathy and signs of inflammation of endolymphatic fluid were visualized on MRI (Fig. 1 ). Positive syphilis serology was also observed on the laboratory work-up (TPHA: 1/5120 and VDRL: 1/4). Lumbar puncture demonstrated signs of lymphocytic meningitis. SARS-CoV-2 Cerebrospinal fluid PCR was negative. Neurosyphilis was suspected but not confirmed (total antibodies by EIA: 2 and RPR antibody index: 0.3). Treatment consisted of intravenous antiviral therapy (aciclovir 750 mg twice daily) for 3 days, followed by ceftriaxone (2 g daily) for 14 days and oral corticosteroids (prednisolone 1 mg/kg daily) in accordance with learned society guidelines [3] for 5 days. Complete recovery of hearing was observed 18 days after starting treatment.

Fig. 1.

Fig. 1

MRI of brain, inner ear and cerebellopontine angles showing bilateral isointense cochleitis on T1-weighted sequences (A), and a hyperintense signal on gadolinium-enhanced T1-weighted sequences (B). The hypointense signal of the endolymph on T2-weighted sequences is in favour of inflammation (C). The hypersignal of both auditory nerves on gadolinium-enhanced T1-weighted sequences is in favour of auditory neuropathy (D). C: cochlea. IAC: Internal auditory canal.

It was very difficult to confirm the aetiology of sudden hearing loss in this case. A previously published clinical case report presented positive SARS-CoV-2 RT-PCR and another synchronous diagnosis (sinonasal polyposis complicated by osteomyelitis of the lateral wall of the sphenoid sinus) in the context of meningoencephalitis [4]. Cases of neurosyphilis with sudden hearing loss have been previously described, confirming the neurotropism of syphilis, but only 2 cases of sudden bilateral hearing loss in a context of polyneuritis have been published [5], [6]. Moreover, anterior labyrinthitis has never been described in the course of this disease. The case reported here could also correspond to neurosyphilis associated with SARS-CoV-2 infection that may have been facilitated by the presence of syphilis, as in HIV-syphilis co-infections [7]. Sudden hearing loss could also have been the direct consequence of SARS-CoV-2 infection in view of the rapid recovery of hearing. Although no definitive conclusion can be reached, comprehensive assessment of this case of sudden hearing loss with positive SARS-CoV-2 RT-PCR would have prevented the serious consequences of neurosyphilis by allowing initiation of appropriate treatment.

Disclosure of interest

The authors declare that they have no competing interest.

References

  • 1.Kilic O., Kalcioglu M.T., Cag Y. Could sudden sensorineural hearing loss be the sole manifestation of COVID-19? An investigation into SARS-COV-2 in the etiology of sudden sensorineural hearing loss. Int J Infect Dis. 2020;97:208–211. doi: 10.1016/j.ijid.2020.06.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Chen X., Fu Y.Y., Zhang T.Y. Role of viral infection in sudden hearing loss. Int Med Res. 2019;47:2865–2872. doi: 10.1177/0300060519847860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Herman P., Vincent C., Parietti Winkler C. Consensus statement. Corticosteroid therapy in ENT in the context of the COVID-19 pandemic. Eur Ann Otorhinolaryngol Head Neck Dis. 2020;137:315–317. doi: 10.1016/j.anorl.2020.04.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Leon A., Debry C., Renaud M. SARS-CoV-2 infection may mask another infection. Eur Ann Otorhinolaryngol Head Neck Dis. 2020;137:349–350. doi: 10.1016/j.anorl.2020.05.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Cassilde A.L., Barnaud G., Baccar S., Mortier E. Sudden-onset bilateral hearing loss revealing early neurosyphilis. Eur Ann Otorhinolaryngol Head Neck Dis. 2014;131:389–391. doi: 10.1016/j.anorl.2014.02.003. [DOI] [PubMed] [Google Scholar]
  • 6.Ibrahim F.W., Malu M.K. Sudden hearing loss in a patient with secondary syphilis. J Laryngol Otol. 2009;123:1262–1265. doi: 10.1017/S0022215109005660. [DOI] [PubMed] [Google Scholar]
  • 7.Centers for disease control prevention Symptomatic early neurosyphilis among HIV-positive men who have sex with men – Four Cities, United States. January 2002–June 2004. MMWR Morb Mortal Wkly Rep. 2007;56:625–628. [PMC free article] [PubMed] [Google Scholar]

Articles from European Annals of Otorhinolaryngology, Head and Neck Diseases are provided here courtesy of Elsevier

RESOURCES